Effects of calcium salts of long-chain fatty acids and rumen-protected methionine on plasma concentrations of ghrelin, glucagon-like peptide-1 (7 to 36) amide and pancreatic hormones in lactating cows These results suggest that the addition of Met to cows given CLFA increases plasma 3 ghrelin and glucagon concentrations associated with the decrease in plasma TG and T-Cho concentrations.
1 Title: Effects of calcium salts of long-chain fatty acids and rumen-protected methionine on plasma concentrations of ghrelin, glucagon-like peptide-1 and Grassland Science Animal Care Committee, and which were formulated to comply with Japanese regulations.
Animals and Management
One primiparous and three multiparous Holstein cows (143.5 ± 3.9 d in milk, calving number: 1.75 ± 0.25, initial body weight: 547.3 ± 14.7 kg) were fed four diets formulated to meet the nutrient requirements according to the Japanese Feeding Standard for Dairy Cattle [13] . The ingredients and composition of the diets are presented in Table 1 . The cows were managed in individual tie stalls, allowed free access to water, and provided experimental diets twice daily at 0900 and 1800 h. They were milked twice daily before each feeding (0840 and 1740 h), and weighed every week.
Treatments and Experimental Design
The cows were used in a 4 × 4 Latin square design in each 2-wk period. Four treatments consist of basal diet only (without supplement), supplemented with CLFA made from palm and soybean oil [Megalac R (Church & Dwight Co., Inc., Princeton, NJ, USA)], with RPM [Lactet SP (Nippon Soda Co., Ltd., Tokyo, Japan)], and with Table 1 CLFA plus RPM. The CLFA containing 85% fatty acids was added to 1.5% of the diet DM, following a previous study [14] . The RPM containing 67% of D-, L-Met was supplemented at 20 g/d for RPM or CLFA plus RPM treatment. Cows were offered each diet ad libitum, allowing for 15% refusal for the first 10 d for each treatment. For the last 4 d of each period, the cows were fed 95% of ad libitum intake for estimating metabolizable energy intake (MEI). Refusals were weighed daily before each morning feeding (0800 h).
Sampling
Samples of the diets and the refusals were collected and pooled for the last 4 d of each period. Milk samples were collected for the last 4 d of each period, added with sodium azide as preservative, and stored at 4℃ until analysis. Blood samples were taken at 12 d from the jugular vein catheter (Argyle 14 G CV catheter kit; Nippon Sherwood Medical Industries Ltd., Tokyo, Japan) inserted on 10 d of each period.
Blood samples (8 mL) were taken at 10 min intervals from 0800 to 1100 h. Cows were milked during bleeding period (-20 and -10 min sampling time), and they were fed just after 0 min sampling. Blood samples were collected into heparinized tubes with aprotinin [500 kilo inhibitor unit (KIU) /mL of blood; Trasylol, Bayer Leverkusen, was measured by competitive solid-phase immunoassay using Eu-labeled synthetic bovine insulin and polystyrene microtiter strips coated with anti-guinea pig γ-globulin.
Intra-and inter-assay coefficients of variation were 2.2 and 1.8%, respectively. Least detectable dose and 50% inhibitory concentration in this assay system were 0.016 and 1.073 ng/mL, respectively. GLP-1 concentration was measured by competitive solid-phase immunoassay based on the method described by Sugino et al. [16] using rat GLP-1 (Peptide Institute, Inc., Osaka, Japan), Eu-labeled rat GLP-1, polystyrene microtiter strips coated with anti-rabbit γ-globulin and anti-human GLP-1 rabbit serum (1:20,000; Yanaihara Institute Inc., Shizuoka, Japan). Intra-and inter-assay of coefficients of variation were 1.7 and 4.8%, respectively. Least detectable dose and 50% inhibitory concentration in this assay system were 0.024 and 0.172 ng/mL, respectively. Plasma glucagon levels were measured every 20 min using a commercially available RIA kit (glucagon assay kit, Daiichi Radioisotope Co. Ltd., Tokyo, Japan).
Glucagon concentrations were measured in the same assay, and the intra-assay coefficient of variation was 3.4%. Least detectable dose and 50% inhibitory concentration in this assay system were 15.6 and 275 pg/mL, respectively.
Plasma glucose concentrations were determined every 10 min using a glucose analyzer (GA-1151; Arkray Co, Ltd., Kyoto, Japan). Plasma β-hydroxy butyrate (BHBA), NEFA, triglyceride (TG), total-cholesterol (T-Cho) and urea nitrogen (UN) concentrations were determined every 20 min using an automated biochemistry analyzer (Beckman Coulter, Inc., Tokyo, Japan).
Statistics
Data for feed intake, milk yield, milk composition and plasma amino acid concentrations were analyzed using the MIXED procedure of SAS (SAS Institute, Inc., Significant differences were set at P < 0.05.
Results

Feed Intake, Milk Yield, and Milk Composition
DMI, milk yield and milk composition are presented in Table 2 . DMI in cows fed CLFA diets compared with cows fed non-CLFA diets was lower (P = 0.025), whereas MEI was not affected. There was no significant effect of RPM on DMI and MEI. Milk yield and composition, except for total solid contents, were unaffected by CLFA and RPM. Milk total solid contents tended to be lower in cows fed CLFA diets compared with cows fed non-CLFA diets (P = 0.107).
Plasma Concentration of Hormones and Metabolites
The changes in plasma concentration of hormones and metabolites are presented in Figures 1 and 2 , respectively. Plasma ghrelin, insulin, glucose, BHBA, NEFA, TG and UN concentrations varied largely through time (P < 0.002, Figures 1 and 2 ), and no significance of the interaction time by treatment was observed (P > 0.192). The time effect for plasma ghrelin, glucose and NEFA concentrations was due to a postprandial decrease. Plasma insulin, BHBA, TG and UN concentrations increased after feeding.
The means of plasma ghrelin concentration were higher (P < 0.001, Table 3 ) in cows fed CLFA compared with cows not fed CLFA. Compared with cows fed Table 2 non-CLFA, plasma glucagon and insulin concentrations in cows fed CLFA were lower (P = 0.002 and P = 0.012, respectively), and plasma GLP-1 concentration tended to be lower (P = 0.061). Plasma insulin concentration tended to be higher (P = 0.092) in cows supplemented RPM than those without RPM. There were interactions between CLFA and RPM for ghrelin and glucagon (P = 0.002 and P = 0.041, respectively):
CLFA plus RPM increased plasma ghrelin, glucagon, but RPM alone did not show such effects.
Compared to those without CLFA, plasma NEFA, TG, T-Cho and UN concentrations in cows fed CLFA were higher (P < 0.001, P = 0.029, P < 0.001, and P < 0.001, respectively), but with lower plasma BHBA concentration (P = 0.006, Table 3 ).
In cows fed RPM diets, plasma glucose concentration was higher (P = 0.001), plasma T-Cho concentration was lower (P = 0.009), and plasma NEFA and UN concentration tended to be lower (P = 0.15 and P = 0.121, respectively). Interactions between CLFA and RPM were observed for TG and T-Cho (P = 0.049 and P = 0.003, respectively):
RPM decreased plasma TG and T-Cho concentrations in cows fed CLFA, but did not affect the cows not fed with CLFA. 
Discussion
High fat inclusion in diets reduces fiber digestion, increases fatty acid absorption, inhibits abomasal motility [18] and increases gut hormone secretion [19, 20] .
Consequently, DMI tends to be depressed. CLFA could prevent such negative effects on ruminal fermentation and fiber digestibility in lactating cows [21, 22] . However, DMI was decreased by CLFA in this study consistent with other reports [23, 24] . RPM did not improve such DMI depression by CLFA contrary to results found by Goulas et al. [8] who used lactating ewes. Additionally, Chillard and Doreau [25] observed no improvement effect of RPM on DMI of cows fed a fish oil supplemented diet during midlactation, although such non-protected fat including high polyunsaturated fatty acids could largely inhibit dietary fiber digestion and depress DMI.
The increase in plasma glucose concentration of cows fed RPM was consistent with Berthiaume et al. [26] , while inconsistent with Bertics and Grummer [27] . Such discrepancies might be explained by the differences in the physiological state of cows (mid vs. early lactation) and energy balance. Plasma NEFA, T-Cho and TG concentrations increased by CLFA in the current study has been previously observed in cows [19, 28] . On the other hand, RPM in cows fed CLFA decreased plasma T-Cho and TG concentrations and tended to decrease plasma NEFA concentration. Met is a methyl group donor for phosphatidylcholine in dairy cows [29] to enhance plasma lipoprotein. In laboratory animals, casein (a Met-rich protein) or L-Met induced hypercholesterolemia in rabbits and rats [30, 31] . In calves, however, high fat diet supplemented with L-Met did not increase plasma VLDL concentration [32] , and Met hydroxyl analog did not affect hepatic TG accumulation in cows [27] . Whether Met enhanced VLDL that was not measured in this study is unknown. On the other hand, because Met is converted to taurine in dairy cows, plasma taurine concentration increased linearly with an increase of postruminal Met infusion [33] . Taurine conjugates with bile acids to become taurocholate in the liver, and promotes lipid absorption and cholesterol consumption [34] . Yagasaki et al. [3] showed that dietary Met and Gly reduced serum T-Cho and increased fecal sterol excretion in rats.
Furthermore, Met, as a sulfur amino acid, suppressed serum NEFA and TG concentration through the control of hormone-sensitive lipase activity and the restoration of lipoprotein lipase activity in peripheral tissues of hepatoma-bearing rats [4] . In this study, therefore, suppression of plasma T-Cho, NEFA and TG with CLFA plus Met might be induced by enhanced uptake and use of lipids by various tissues.
The increase in plasma ghrelin concentration of cows fed CLFA is consistent with that of rats that ingested some fatty acids [35] . In addition, RPM decreased plasma ghrelin concentration in cows not fed CLFA, whereas CLFA plus RPM compared with CLFA alone tended to increase plasma ghrelin concentration.
Thus, only a simultaneous inclusion of CLFA and RPM may enhance ghrelin secretion via the changes in lipid metabolism. Ghrelin enhances food intake in both nonruminants [36] and ruminants [37, 38] . As a result, we could not find the relationship between plasma ghrelin concentration and feed intake in this study. Since reports on ghrelin responses to lipid metabolism in ruminants are limited, further research is desirable. Plasma insulin concentration decreased in cows fed CLFA with decreasing DMI consistent with previous reports [23, 43] . We consider that insulin depression might be due to lessor volatile fatty acids (VFA) production caused by decreased DMI.
Although we did not determine plasma VFA concentrations, CLFA decreased plasma BHBA concentration, derived from butyrate by rumen fermentation. And, we also observed that plasma GLP-1 concentration tended to decrease at the same time,
suggesting decreased GLP-1, which stimulates insulin secretion, may be related to insulin depression in cows fed CLFA.
CLFA also decreased plasma glucagon concentration. Our result is consistent with that of Cummins and Sartin [43] , but inconsistent with that of Khorasani and Kennelly [44] . In several species, elevated NEFA decreases plasma glucagon concentration [45, 46] . However, the present results showed that the decrease of plasma glucagon with CLFA was attenuated by RPM. In our previous study, glucagon secretion was more strongly enhanced when amino acids and ghrelin were simultaneously administered compared with the administration of ghrelin alone in lactating cows [11] . In addition, RPM tended to depress plasma NEFA concentration of cows fed CLFA. Therefore, we consider that increased Met absorption, higher plasma ghrelin concentration and a decreased plasma NEFA concentration might modulate plasma glucagon depression in CLFA-fed cows.
The present study did not show any favorable effects of RPM on feed intake and milk production in cows fed with CLFA although plasma ghrelin concentration increased. Further studies are desirable to elucidate the effects of lactating stage and
Met supplemental level with CLFA on DMI and milk production. 
